This inventor holds 1 USPTO granted patent and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Alex Godwood: Innovator in Rheumatoid Arthritis Biomarkers
Introduction
Alex Godwood is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of medical diagnostics, particularly in the treatment of rheumatoid arthritis. His innovative work focuses on the use of biomarkers to enhance clinical responses in patients.
Latest Patents
Alex holds a patent titled "Anti-PAD4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritis." This patent relates to the use of anti-PAD4 autoantibodies as a clinical biomarker for rheumatoid arthritis (RA) treatment. The disclosure further provides an assay to detect these autoantibodies, assay kits for their detection, as well as computer-implemented diagnostic methods. He has 1 patent to his name.
Career Highlights
Alex is currently employed at MedImmune Limited, where he continues to develop innovative solutions in the field of immunology. His work is pivotal in advancing the understanding and treatment of autoimmune diseases.
Collaborations
Alex collaborates with talented individuals in his field, including Rachel Patricia Moate and Ethan Grant. Their combined expertise contributes to the ongoing research and development efforts at MedImmune Limited.
Conclusion
Alex Godwood's contributions to the field of rheumatoid arthritis treatment through innovative biomarker research are commendable. His work not only enhances clinical practices but also paves the way for future advancements in medical diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile